NFKB1 and bacterial meningitis: Signaling pathway inhibitors have been used in bacterial meningitis, such as U0126 (MAPK inhibitor), CAY10657, or BAY-11072 (NF-κB inhibitor), which could effectively inhibit neuroinflammation in vitro.